Company: DMAC
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001437749-25-038211
Chunk: 3

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                      Manner of Filing          
   Number                                                                                                 
     99.1      Press Release dated December 18, 2025                            Furnished Electronically  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (formatted as inline XBRL)      Filed Electronically      

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               DIAMEDICA THERAPEUTICS INC.                                             
  Date: December 18, 2025      By:                              /s/ Scott Kellen                       
                                                                Scott Kellen                           
                                                                Chief Financial Officer and Secretary